Trial intelligence / Profile preview

Differences in antihypertensive drug levels: elderly vs young 2

2020-003647-28Phase 4Active

Start
Oct 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of losartan and perindopril in hypertension (HTN) (2 cohorts). Primary endpoint: AUC of losartan and perindopril over 24 hours in elderly vs young. Started Oct 2020; status: active.

02

Drugs

losartanperindopril
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on 2020-003647-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-003647-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call